StonvexLoading…
StonvexStonvexStonvexCore line items from CRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $905.00M | $2.91B | $2.23B | $1.52B |
Operating Income | $-711.00M | $598.00M | $551.00M | $453.00M |
Net Income | $-711.00M | $363.00M | $351.00M | $287.00M |
EPS (Diluted) | $-8.02 | $4.15 | $3.97 | $3.18 |
Total Assets | $7.15B | $7.40B | $6.75B | $6.71B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $40.00M | $132.00M | $196.00M | $72.00M |
Free Cash Flow OCF − CapEx | $-32.00M | $543.00M | $428.00M | $240.00M |
Shares Outstanding | 88.79M | 88.75M | 83.71M | 83.68M |